Journal of Interdisciplinary Genomics

Interdisciplinary Society of Genetic & Genomic Medicine (유전의학융합회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Synthetic CaM and NFAT Oligodeoxynucleotide on MPP+-Stimulated Mesencephalic Neurons

  • Jihyun Park (Department of Pathology, College of Medicine, Catholic University of Daegu) ;
  • Kyung Mi Jang (Department of Pediatrics, College of Medicine, Yeungnam University)
  • Received : 2023.09.28
  • Accepted : 2023.10.26
  • Published : 2023.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Ca2+ signaling plays a vital role in neuronal signaling and altered Ca2+ homeostasis in Parkinson's disease (PD). Overexpression of αSYN significantly promote the Ca2+-Calmodulin (CaM) activity and subsequent nuclear translocation of nuclear factor of activated T cells (NFAT) transcription factor in dopaminergic neurons of midbrain. However, the exact role of Ca2+-CaM and NFAT in PD pathology is yet to be elucidated. Methods: We designed the CaM-NFAT-oligodeoxynucleotide (ODN), a synthetic short DNA containing complementary sequence for NFAT transcription factor and CaM mRNA. Then, the effect of CaM-NFAT-ODN on 1-methyl-4-phenylpyridinium (MPP+)-mediated neurotoxicity was investigated in mimic PD model in vitro. Results: First, the expression of αSYN and CaM was strongly increased in substantia nigra (SN) of PD and the expression of tyrosine hydroxylase (TH) was strongly increased in control SN. Additionally, the expression of apoptosis marker proteins was strongly increased in SN of PD. Transfection of CaM-NFAT-ODN repressed CaM and pNFAT, the target genes of this ODN in rat embryo primary mesencephalic neurons. It also reduced ERK phosphorylation, a downstream target of these genes. These results demonstrated that CaM-NFAT-ODN operated successfully in rat embryo primary mesencephalic neurons. Transfection of CaM-NFAT-ODN repressed TH reduction, αSYN accumulation, and apoptosis by MPP+-induced neurotoxicity response through Ca2+ signaling and mitogen-activated protein kinases (MAPK) signaling. Conclusion: Synthetic CaM-NFAT-ODN has substantial therapeutic feasibility for the treatment of neurodegenerative diseases.

Keywords

Acknowledgement

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (NRF-2021R1I1A1A01060030).

References

  1. Zhao D, Feng PJ, Liu JH, Dong M, Shen XQ, Chen YX, et al. Electromagnetized-nanoparticle-modulated neural plasticity and recovery of degenerative dopaminergic neurons in the mid-brain. Advanced Materials 2020;32:2003800. doi: 10.1002/adma.202003800.
  2. Wu J, Xu X, Zheng L, Mo J, Jin X, Bao Y. Nilotinib inhibits microglia-mediated neuroinflammation to protect against dopaminergic neuronal death in Parkinson's disease models. International Immunopharmacology 2021;99:108025. doi: 10.1016/j.intimp.2021.108025.
  3. Wang X, Cao G, Ding D, Li F, Zhao X, Wang J, et al. Ferruginol prevents degeneration of dopaminergic neurons by enhancing clearance of α-synuclein in neuronal cells. Fitoterapia 2022;156: 105066. doi: 10.1016/j.fitote.2021.105066.
  4. Lieberman OJ, Choi SJ, Kanter E, Saverchenko A, Frier MD, Fiore GM, et al. α-Synuclein-dependent calcium entry underlies differential sensitivity of cultured sn and vta dopaminergic neurons to a parkinsonian neurotoxin. eNeuro 2017;4. doi: 10.1523/eneuro.0167-17.2017.
  5. Sun Y, Zhang H, Selvaraj S, Sukumaran P, Lei S, Birnbaumer L, et al. Inhibition of L-type Ca2+ channels by TRPC1-STIM1 complex is essential for the protection of dopaminergic neurons. Journal of Neuroscience 2017;37:3364-77. doi: 10.1523/JNEUROSCI.3010-16.2017.
  6. Chen L, Huang Y, Yu X, Lu J, Jia W, Song J, et al. Corynoxine protects dopaminergic neurons through inducing autophagy and diminishing neuroinflammation in rotenone-induced animal models of parkinson's disease. Front Pharmacol 2021;12:642900. doi: 10.3389/fphar.2021.642900.
  7. Park J, Jang KM, Park KK. Effects of apamin on MPP(+)-induced calcium overload and neurotoxicity by targeting CaMKII/ERK/p65/STAT3 signaling pathways in dopaminergic neuronal cells. Int J Mol Sci 2022;23. doi: 10.3390/ijms232315255.
  8. Pawar A, Pardasani KR. Computational model of calcium dynamics-dependent dopamine regulation and dysregulation in a dopaminergic neuron cell. The European Physical Journal Plus 2023;138:30. doi: 10.1140/epjp/s13360-023-03691-1.
  9. Chen L, Song M, Yao C. Calcineurin in development and disease. Genes & Diseases 2022;9:915-27. doi: 10.1016/j.gendis.2021.03.002.
  10. Bohush A, Lesniak W, Weis S, Filipek A. Calmodulin and its binding proteins in Parkinson's disease. Int J Mol Sci 2021;22. doi: 10.3390/ijms22063016.
  11. Ren R, Guo J, Chen Y, Zhang Y, Chen L, Xiong W. The role of Ca2+/Calcineurin/NFAT signalling pathway in osteoblastogenesis. Cell Proliferation 2021;54:e13122.
  12. An S. The emerging role of extracellular Ca(2+) in osteo/odontogenic differentiation and the involvement of intracellular Ca (2+) signaling: from osteoblastic cells to dental pulp cells and odontoblasts. J Cell Physiol 2019;234:2169-93. doi: 10.1002/jcp.27068.
  13. Sant'Anna R, Robbs BK, Freitas JAd, Santos PPd, Konig A, Outeiro TF, et al. Alpha-synuclein oligomers activate NFAT proteins modulating synaptic homeostasis and apoptosis. bioRxiv 2023: 2023.02.21.529374. doi: 10.1101/2023.02.21.529374.
  14. Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 2003;17:2205-32. doi: 10.1101/gad.1102703.
  15. Mognol GP, Carneiro FRG, Robbs BK, Faget DV, Viola JPdB. Cell cycle and apoptosis regulation by NFAT transcription factors: new roles for an old player. Cell death & disease 2016;7:e2199. doi: 10.1038/cddis.2016.97.
  16. Park J, Jang KM, Park KK. Apamin suppresses LPS-induced neuroinflammatory responses by regulating sk channels and TLR4- mediated signaling pathways. Int J Mol Sci 2020;21. doi: 10.3390/ijms21124319.
  17. Gu H, An HJ, Gwon MG, Bae S, Zouboulis CC, Park KK. The effects of synthetic SREBP-1 and PPAR-gamma decoy oligodeoxynucleotide on acne-like disease in vivo and in vitro via lipogenic regulation. Biomolecules 2022;12. doi: 10.3390/biom12121858.
  18. Bennett CF, Swayze EE. RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annual Review of Pharmacology and Toxicology 2010; 50:259-93. doi: 10.1146/annurev.pharmtox.010909.105654.
  19. Mann MJ, Dzau VJ. Therapeutic applications of transcription factor decoy oligonucleotides. The Journal of Clinical Investigation 2000;106:1071-5. doi: 10.1172/JCI11459.
  20. Lee SJ, Kim YA, Park KK. Anti-Fibrotic effect of synthetic noncoding decoy ODNs for TFEB in an animal model of chronic kidney disease. International Journal of Molecular Sciences 2022; 23:8138. doi: 10.3390/ijms23158138.
  21. Gwon MG, Leem J, An HJ, Gu H, Bae S, Kim JH, et al. The decoy oligodeoxynucleotide against HIF-1α and STAT5 ameliorates atopic dermatitis-like mouse model. Molecular Therapy-Nucleic Acids 2023;34:102036. doi: 10.1016/j.omtn.2023.102036.
  22. Kim KH, Park KK. Small RNA-and DNA-based gene therapy for the treatment of liver cirrhosis, where we are? World Journal of Gastroenterology: WJG 2014;20:14696-705. doi: 10.3748/wjg.v20.i40.14696.
  23. Kim JY, An HJ, Kim WH, Gwon MG, Gu H, Park YY, et al. Antifibrotic effects of synthetic oligodeoxynucleotide for TGF-beta1 and smad in an animal model of liver cirrhosis. Mol Ther Nucleic Acids 2017;8:250-63. doi: 10.1016/j.omtn.2017.06.022.
  24. Park JH, Seo YH, Jang JH, Jeong CH, Lee S, Park B. Asiatic acid attenuates methamphetamine-induced neuroinflammation and neurotoxicity through blocking of NF-kB/STAT3/ERK and mitochondria-mediated apoptosis pathway. J Neuroinflammation 2017;14:240. doi: 10.1186/s12974-017-1009-0.
  25. Nam JH, Park ES, Won SY, Lee YA, Kim KI, Jeong JY, et al. TRPV1 on astrocytes rescues nigral dopamine neurons in Parkinson's disease via CNTF. Brain 2015;138(Pt 12):3610-22. doi: 10.1093/brain/awv297.
  26. Bohush A, Lesniak W, Weis S, Filipek A. Calmodulin and its binding proteins in Parkinson's disease. International Journal of Molecular Sciences 2021;22:3016. doi: 10.3390/ijms22063016.
  27. Chen TS, Koutsilieri E, Rausch WD. MPP+ selectively affects calcium homeostasis in mesencephalic cell cultures from embryonal C57/B16 mice. Journal of Neural Transmission/General Section JNT 1995;100:153-63. doi: 10.1007/BF01271538.
  28. Egunlusi AO, Malan SF, Omoruyi SI, Ekpo OE, Palchykov VA, Joubert J. Open and rearranged norbornane derived polycyclic cage molecules as potential neuroprotective agents through attenuation of MPP(+)- and calcium overload-induced excitotoxicity in neuroblastoma SH-SY5Y cells. Eur J Med Chem 2020;204:112617. doi: 10.1016/j.ejmech.2020.112617.
  29. Swart T, Hurley MJ. Calcium channel antagonists as disease-modifying therapy for Parkinson's disease: therapeutic rationale and current status. Cns Drugs 2016;30:1127-35. doi: 10.1007/s40263-016-0393-9.
  30. Park J, Jang KM, Park KK. Apamin suppresses LPS-induced neuroinflammatory responses by regulating SK channels and TLR4-mediated signaling pathways. International Journal of Molecular Sciences 2020;21:4319. doi: 10.3390/ijms21124319.
  31. Lee DH, Han YS, Han ES, Bang H, Lee CS. Differential involvement of intracellular Ca 2+ in 1-methyl-4-phenylpyridinium-or 6-hydroxydopamine-induced cell viability loss in PC12 cells. Neurochemical Research 2006;31:851-60. doi: 10.1007/s11064-006-9088-9.
  32. Sompol P, Furman JL, Pleiss MM, Kraner SD, Artiushin IA, Batten SR, et al. Calcineurin/NFAT signaling in activated astrocytes drives network hyperexcitability in Aβ-bearing mice. Journal of Neuroscience 2017;37:6132-48. doi: 10.1523/JNEUROSCI.0877-17.2017.
  33. Sticozzi C, Belmonte G, Meini A, Carbotti P, Grasso G, Palmi M. IL-1β induces GFAP expression in vitro and in vivo and protects neurons from traumatic injury-associated apoptosis in rat brain striatum via NFκB/Ca2+-calmodulin/ERK mitogen-activated protein kinase signaling pathway. Neuroscience 2013;252:367-83. doi: 10.1016/j.neuroscience.2013.07.061.